CLUSTER filed Aug 13, 2026 at 16:37 ET
A cluster of insider selling at Charles River Laboratories (CRL) totaling $10.21M occurred within 9 days of the Q2 2026 earnings beat. The selling is concentrated among a director (Foster, $7.9M), a CEVP (Parisotto, $1.04M), and an EVP (Creamer, $1.08M), all of which are open-market sales. While the earnings report was bullish (beat on EPS, raised guidance), the insider sales are likely liquidity-driven, as they coincide with option exercises and vesting, and the total value represents only 0.075% of the $13.6B market cap, falling below the 0.1% materiality threshold. The cluster is not a bearish signal given the small proportional size and the context of post-earnings window openings, but it warrants monitoring for any follow-on sales by the CEO or CFO.